DEEPAKNTR

is slowly climbing the chemical value chain

Revenue up 16% and profits up 20% to ₹286 crores shows they're moving in the right direction, especially with their specialty chemicals now hitting 30% of revenue. The phenolics demand spike is helping margins, and their downstream integration into dyes and refined chemicals is starting to show promise. But this is still a cyclical, working capital-heavy business that gets jerked around by crude oil prices and global demand swings. Inventory days haven't improved much, which means they're still tying up a lot of cash in stock. That's always been the Achilles heel of chemical companies - you need massive working capital just to stay in business. The strategy makes sense though. Instead of just making basic chemicals where everyone competes on price, they're trying to move into specialty products with better margins and customer stickiness. If they can execute this downstream push while keeping costs under control, there's real upside here. Track